NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 31 filers reported holding NEUROCRINE BIOSCIENCES INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SONA ASSET MANAGEMENT (US) LLC | 14,375,000 | $18,475,584 | 3.83% |
| CSS LLC/IL | 15,659,000 | $19,952,839 | 1.24% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 20,905,000 | $26,686,477 | 0.56% |
| SSI INVESTMENT MANAGEMENT LLC | 2,443,000 | $3,108,728 | 0.22% |
| Paloma Partners Management Co | 3,125,000 | $3,989,479 | 0.14% |
| LORD, ABBETT & CO. LLC | 8,709,000 | $11,119 | 0.04% |
| FRANKLIN RESOURCES INC | 54,750,000 | $70,216,875 | 0.03% |
| Rock Springs Capital Management LP | 1,000,000 | $1,276,050 | 0.03% |
| Warberg Asset Management LLC | 86,000 | $109,667 | 0.02% |
| BNP Paribas Asset Management Holding S.A. | 3,100,000 | $3,940 | 0.01% |
| Invesco Ltd. | 23,914,000 | $30,430,565 | 0.01% |
| Leucadia National | 530,000 | $675,272 | 0.01% |
| AGF MANAGEMENT LTD | 700,000 | $890,750 | 0.01% |
| WELLS FARGO & COMPANY/MN | 13,378,000 | $17,019,090 | 0.01% |
| D. E. Shaw & Co., Inc. | 2,500,000 | $3,176,523 | 0.00% |
| FIRST HAWAIIAN BANK | 47,000 | $59,808 | 0.00% |
| PUTNAM INVESTMENTS LLC | 778,000 | $990,005 | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 10,000 | $12,725 | 0.00% |
| Capital Analysts, LLC | 2,000 | $3 | 0.00% |
| UBS Group AG | 1,000 | $1,273 | 0.00% |
This page lists NEUROCRINE BIOSCIENCES INC's shareholders in Q2 2023. To view NEUROCRINE BIOSCIENCES INC's shareholder history, click here.